Home LiteratureArticle Details
PMID: 6754617 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans.

Infection and immunity ·Vol. 38 ·No. 1 ·1982-10-00 ·Pages 380-2

Diamond RD, Erickson NF

Abstract

Chemotaxis of human neutrophils and monocytes was stimulated by sera activated with greater than or equal to 1.25 x 10(6) Cryptococcus neoformans. Leukocytes from five renal transplant recipients had depressed chemotactic responses to C. neoformans-activated sera when compared with normal subjects (P less than 0.05). Concentrations of cryptococcal capsular polysaccharide less than 1 mg/ml failed to generate chemotactic factors from sera.

MeSH Terms
Chemotactic Factors/physiology Chemotaxis, Leukocyte Cryptococcus/physiology Cryptococcus neoformans/physiology Humans Hydrocortisone/pharmacology Immunosuppression Therapy Kidney Transplantation Lymphoma/blood Monocytes/physiology Neutrophils/physiology Polysaccharides, Bacterial/physiology
Chemicals
Chemotactic Factors Polysaccharides, Bacterial Hydrocortisone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Diamond R D
Erickson N F
References (13)
13 references, click to expand
  1. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
    J Infect Dis. 1972 Apr;125(4):367-76 PMID: 4553080
  2. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
    J Exp Med. 1973 Feb 1;137(2):387-410 PMID: 4568301
  3. Prognostic factors in cryptococcal meningitis. A study in 111 cases.
    Ann Intern Med. 1974 Feb;80(2):176-81 PMID: 4811791
  4. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    J Immunol. 1974 Jun;112(6):2260-70 PMID: 4596700
  5. The selective eosinophil chemotactic activity of histamine.
    J Exp Med. 1975 Dec 1;142(6):1462-76 PMID: 450
  6. Abnormal chemotaxis in patients with cutaneous anergy.
    Mayo Clin Proc. 1977 Mar;52(3):196-201 PMID: 300135
  7. Complement depletion in cryptococcal sepsis.
    J Immunol. 1978 May;120(5):1686-90 PMID: 351055
  8. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.
    Infect Immun. 1979 Nov;26(2):435-40 PMID: 397927
  9. Massive antigenemia during disseminated cryptococcosis.
    Mayo Clin Proc. 1980 Aug;55(8):513-5 PMID: 7401694
  10. Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro.
    J Clin Invest. 1981 Jan;67(1):173-82 PMID: 6256411
  11. [Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans].
    Ann Inst Pasteur (Paris). 1951 Dec;81(6):674-6 PMID: 14933889
  12. Natural host resistance to infection with Cryptococcus neoformans. I. The effect of the properdin system on the experimental disease.
    J Infect Dis. 1961 Sep-Oct;109:147-53 PMID: 13896119
  13. CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
    J Immunol. 1965 Jun;94:916-20 PMID: 14321434
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1982-10-00
Pages
380-2
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC347742
Subset
IM
Grants
NIAID NIH HHS · AI15338 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com